Male Breast Cancer: Clinicopathological, Immunohistochemical and Radiological Study

Objective: To evaluate the pathological and radiological features, immunohistochemical profile and treatment methods of primary male breast carcinoma cases diagnosed at our center. Material and Method: The pathology archive between 2006 and 2019 was reviewed and the data of 27 male patients diagnos...

Full description

Bibliographic Details
Main Authors: Bermal HASBAY, Filiz AKA BOLAT, Hüseyin Özgür AYTAÇ, Murat KUŞ, Ayşin POURBAGHER
Format: Article
Language:English
Published: Federation of Turkish Pathology Societies 2020-09-01
Series:Türk Patoloji Dergisi
Subjects:
Online Access: http://www.turkjpath.org/pdf.php3?id=1930
id doaj-fc703e76431f4394aef5993a581b0902
record_format Article
spelling doaj-fc703e76431f4394aef5993a581b09022020-11-25T03:39:29ZengFederation of Turkish Pathology SocietiesTürk Patoloji Dergisi1018-56151309-57302020-09-0136321121710.5146/tjpath.2020.01490Male Breast Cancer: Clinicopathological, Immunohistochemical and Radiological StudyBermal HASBAYFiliz AKA BOLATHüseyin Özgür AYTAÇMurat KUŞAyşin POURBAGHERObjective: To evaluate the pathological and radiological features, immunohistochemical profile and treatment methods of primary male breast carcinoma cases diagnosed at our center. Material and Method: The pathology archive between 2006 and 2019 was reviewed and the data of 27 male patients diagnosed as primary breast cancer were retrospectively evaluated. Results: The age of the patients ranged between 40-86 years. The left breast was involved in 17 patients. The mean tumor diameter was 2.35 ± 1.09 cm. Of the 27 cases, 8 were dead and 19 were alive. The mean follow-up duration was 37.45 ± 24.84 months. The mean estimated life expectancy was 65±14.7 months. The most common complaint was a swelling in the breast. The time interval between the onset of complaints and admittance to hospital ranged from three months to two years. The most common histopathological diagnosis was invasive carcinoma - no special type. The most common surgical procedure was mastectomy with lymph node dissection. Nine patients had metastatic lymph nodes. In terms of the hormone profiles, 24 were Estrogen receptor positive, 21 were Progesterone receptor positive and six were Her2/neu positive. Three patients had triple-negative tumors. Conclusion: Male breast carcinoma is a rare disease but its frequency has been increasing recently. As breast cancer is more commonly attributed to women, the diagnosis is usually delayed until later stages in males. Public awareness should therefore be increased and breast cancer should be considered in the differential diagnosis especially in the presence of breast swelling and complaints related to the breast skin so that the appropriate biopsy can be obtained without delay. http://www.turkjpath.org/pdf.php3?id=1930 male breast cancerdiagnosissurvival
collection DOAJ
language English
format Article
sources DOAJ
author Bermal HASBAY
Filiz AKA BOLAT
Hüseyin Özgür AYTAÇ
Murat KUŞ
Ayşin POURBAGHER
spellingShingle Bermal HASBAY
Filiz AKA BOLAT
Hüseyin Özgür AYTAÇ
Murat KUŞ
Ayşin POURBAGHER
Male Breast Cancer: Clinicopathological, Immunohistochemical and Radiological Study
Türk Patoloji Dergisi
male breast cancer
diagnosis
survival
author_facet Bermal HASBAY
Filiz AKA BOLAT
Hüseyin Özgür AYTAÇ
Murat KUŞ
Ayşin POURBAGHER
author_sort Bermal HASBAY
title Male Breast Cancer: Clinicopathological, Immunohistochemical and Radiological Study
title_short Male Breast Cancer: Clinicopathological, Immunohistochemical and Radiological Study
title_full Male Breast Cancer: Clinicopathological, Immunohistochemical and Radiological Study
title_fullStr Male Breast Cancer: Clinicopathological, Immunohistochemical and Radiological Study
title_full_unstemmed Male Breast Cancer: Clinicopathological, Immunohistochemical and Radiological Study
title_sort male breast cancer: clinicopathological, immunohistochemical and radiological study
publisher Federation of Turkish Pathology Societies
series Türk Patoloji Dergisi
issn 1018-5615
1309-5730
publishDate 2020-09-01
description Objective: To evaluate the pathological and radiological features, immunohistochemical profile and treatment methods of primary male breast carcinoma cases diagnosed at our center. Material and Method: The pathology archive between 2006 and 2019 was reviewed and the data of 27 male patients diagnosed as primary breast cancer were retrospectively evaluated. Results: The age of the patients ranged between 40-86 years. The left breast was involved in 17 patients. The mean tumor diameter was 2.35 ± 1.09 cm. Of the 27 cases, 8 were dead and 19 were alive. The mean follow-up duration was 37.45 ± 24.84 months. The mean estimated life expectancy was 65±14.7 months. The most common complaint was a swelling in the breast. The time interval between the onset of complaints and admittance to hospital ranged from three months to two years. The most common histopathological diagnosis was invasive carcinoma - no special type. The most common surgical procedure was mastectomy with lymph node dissection. Nine patients had metastatic lymph nodes. In terms of the hormone profiles, 24 were Estrogen receptor positive, 21 were Progesterone receptor positive and six were Her2/neu positive. Three patients had triple-negative tumors. Conclusion: Male breast carcinoma is a rare disease but its frequency has been increasing recently. As breast cancer is more commonly attributed to women, the diagnosis is usually delayed until later stages in males. Public awareness should therefore be increased and breast cancer should be considered in the differential diagnosis especially in the presence of breast swelling and complaints related to the breast skin so that the appropriate biopsy can be obtained without delay.
topic male breast cancer
diagnosis
survival
url http://www.turkjpath.org/pdf.php3?id=1930
work_keys_str_mv AT bermalhasbay malebreastcancerclinicopathologicalimmunohistochemicalandradiologicalstudy
AT filizakabolat malebreastcancerclinicopathologicalimmunohistochemicalandradiologicalstudy
AT huseyinozguraytac malebreastcancerclinicopathologicalimmunohistochemicalandradiologicalstudy
AT muratkus malebreastcancerclinicopathologicalimmunohistochemicalandradiologicalstudy
AT aysinpourbagher malebreastcancerclinicopathologicalimmunohistochemicalandradiologicalstudy
_version_ 1724538474204233728